Exanthème à type de « syndrome babouin » au cours d’une primo-infection par le parvovirus B19 : deux cas

Dubois, Arnaud; Thellier, Sylvie; Wierzbicka-Hainaut, E.; Pierre, Fabrice H.F.; Anyfantakis, V.; Guillet, G.

doi:10.1016/j.annder.2010.06.023

Cited by 14 publications

(5 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The clinical scenario which we encountered was consistent with the above mentioned clinical features [2,3]. SDRIFE usually arises within a few hours to days following administration of the so-called offending agents, though it is also known to be triggered by infections [1,4,5]. Most cases spontaneously resolve via desquamation within 1 to 2 weeks which was the case with our patient also.…”

Section: Sdrife-like Rash With Covid -19supporting

confidence: 88%

“…SDRIFE has been commonly associated with beta-lactams, antihypertensives, radiocontrast media, chemotherapeutic agents and biologics, though its occurrence has also been described in the absence of previous drug exposure [2,3]. There are reports of SDRIFE-like rashes associated with infections including parvovirus infections and of late, in coronavirus disease 19 (COVID-19) patients [1,4,5].…”

Section: Sdrife-like Rash With Covid -19mentioning

confidence: 99%

See 1 more Smart Citation

SDRIFE-Like Rash With COVID - 19

et al. 2021

View full text Add to dashboard Cite

Section: Sdrife-like Rash With Covid -19supporting

confidence: 88%

Section: Sdrife-like Rash With Covid -19mentioning

confidence: 99%

SDRIFE-Like Rash With COVID - 19

et al. 2021

View full text Add to dashboard Cite

“…The rash described here appeared to us reminiscent of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), a condition that has been regularly reported in association with the intake of certain drugs, but also more rarely in association with a viral infection, such as primary parvovirus B19 infection. 3,4 The role of paracetamol could also be discussed here but, in addition to the fact that paracetamol has been only exceptionally reported as a cause of SDRIFE, 5 the rash disappeared despite the continuation of the drug, an unusual occurrence in drug reactions.…”

Section: A Distinctive Skin Rash Associated With Coronavirus Disease mentioning

confidence: 95%

“…Concern about the impact on the South was great due to the chronic shortage of facilities and limited intensive care equipment. In Sardinia, with a population of 1 640 000 inhabitants, 3 the institutional recognition found only 20 intensive care beds available to welcome COVID-19 cases. A strategic plan will increase the number to 224 beds, but full implementation would require time (Resolution of the Regional Council 11/17 of the 11/03/2020).…”

Section: A Distinctive Skin Rash Associated With Coronavirus Disease mentioning

confidence: 99%

A distinctive skin rash associated with coronavirus disease 2019?

Mahé

Birckel

Krieger

et al. 2020

Acad Dermatol Venereol

139

132

View full text Add to dashboard Cite

COVID-19 and Cutaneous manifestations Dear Editor We found that the article on 'Cutaneous manifestations in COVID-19: a first perspective' is very interesting. 1 Recalcati noted that 20.4% of the patients have cutaneous problem and mentioned that this is the first report on this clinical aspect of COVID-19. The wide spectrum of dermatological problem in patients with COVID-19 is an interesting clinical data. Based on our experiences in Thailand, the second country that COVID-19 occurred, almost all patients have no significant dermatological presentation. In fact, in caring patient with severe illness, skin disorder might not be completely investigated. The role of dermatologist in caring COVID-19 patients might be overlooked. An important question is whether the dermatological problem in COVID-19 has any clinical impact on diagnosis and treatment of disease. Some skin disorders in COVID-19 might result in missed diagnosis. For example, the petechiae rash might result in incorrect diagnosis as dengue.

show abstract

“…Some viral infections may be accompanied by intertriginous involvement, which is associated with Parvovirus B19 infection was described in two adult patients and associated with EBV and CMV infection was described in a paediatric patient. 8,9 The perineal eruption, which is one of the early characteristic findings in Kawasaki syndrome, is also localised to the genital intertriginous area, occurs within the first 6 days of the disease, and presents as a diffuse macular plaque-type erythema. 10 In our study, the symmetrical intertriginous distribution of rash was markedly observed in half of our patients with mucocutaneous manifestation.…”

Section: Discussionmentioning

confidence: 99%

New dermatological findings of MIS‐C: Can mucocutaneous involvement be associated with Severe Disease Course?

et al. 2022

View full text Add to dashboard Cite

Background:Little is known about mucocutaneous involvement in critically ill patients with the multisystem inflammatory syndrome in children (MIS-C). The aim of our study was to describe the localisation and variety of rash and to investigate whether presenting with rash at admission alters the clinical course of MIS-C. Methods:This prospective, observational cohort study was conducted amongst children under 18 years of age who were admitted to our paediatric intensive care unit (PICU) between May 2020 and May 2021 with a possible diagnosis of MIS-C.Results: A total of 33 children with MIS-C, 21 boys (64%), with a median age of 9.4 years (3.4-11.5) were enrolled. Twenty-four children presented with mucocutaneous symptoms (72%). Age, male gender, PICU length of stay, presenting symptoms, inotrope requirement, the existence of myocarditis or respiratory failure were higher but not significantly different in patients with rash compared to those without rash (P > 0.05). The median duration of symptoms before admission and presence of cervical lymphadenopathy were significantly higher in patients than those without rash (P < 0.05). Children with a rash had a significantly higher neutrophil count, CRP, procalcitonin, troponin levels and lower lymphocyte counts and albumin levels than those without rash (P < 0.05). Twelve children with rash (50%) had symmetrical intertriginous distribution. Two children had erythematous lesions on the areola and the surroundings.In conclusion, intertriginous involvement, periareolar erythema and other mucocutaneous manifestations might be the first alarming symptoms of moderate to severe MIS-C. Therefore, close monitoring with a multidisciplinary approach should be considered for these patients to assess potential disease progression.

show abstract

Exanthème à type de « syndrome babouin » au cours d’une primo-infection par le parvovirus B19 : deux cas

Cited by 14 publications

References 12 publications

SDRIFE-Like Rash With COVID - 19

SDRIFE-Like Rash With COVID - 19

A distinctive skin rash associated with coronavirus disease 2019?

New dermatological findings of MIS‐C: Can mucocutaneous involvement be associated with Severe Disease Course?

Contact Info

Product

Resources

About